Clinical Trials List
2022-12-01 - 2027-12-31
Phase III
Recruiting3
Terminated2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Po-Hao Huang 風濕免疫科
- 黃建中 無
- 張詩欣 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ping-Han Tsai Division of Rheumatology
- TianMing Zhan Division of Rheumatology
- 賴振宏 風濕免疫科
- 陳彥輔 Division of Rheumatology
- 張哲慈 Division of Rheumatology
- Shue-Fen Lo Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzn-Min Lin Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsien-Tzung Liao Division of Rheumatology
- Ming-Han Chen Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
200 participants
